{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:06:40Z","timestamp":1792638400633,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ebiom.2022.104149","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T13:21:41Z","timestamp":1657286501000},"page":"104149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-8856","authenticated-orcid":false,"given":"Ma\u00eflys","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-3810","authenticated-orcid":false,"given":"Patricia","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4910-1289","authenticated-orcid":false,"given":"Marion Le","family":"Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-0674","authenticated-orcid":false,"given":"Marie-Pierre","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Matteudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Agavnian-Couquiaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Keime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duje","family":"Buric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Bourgarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Ayrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-7317","authenticated-orcid":false,"given":"Manon","family":"Carr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ebiom.2022.104149_bib0001","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","article-title":"Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study","volume":"18","author":"Schwalbe","year":"2017","journal-title":"Lancet Oncol"},{"issue":"7663","key":"10.1016\/j.ebiom.2022.104149_bib0002","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature22973","article-title":"The whole-genome landscape of medulloblastoma subtypes","volume":"547","author":"Northcott","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104149_bib0003","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00401-019-02020-0","article-title":"Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes","volume":"138","author":"Sharma","year":"2019","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.ebiom.2022.104149_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.critrevonc.2016.05.012","article-title":"Childhood medulloblastoma","volume":"105","author":"Massimino","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104149_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3171\/2019.5.PEDS18381","article-title":"Medulloblastoma in the age of molecular subgroups: a review","volume":"24","author":"Juraschka","year":"2019","journal-title":"J Neurosurg Pediatr"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104149_bib0006","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"10.1016\/j.ebiom.2022.104149_bib0007","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1200\/JCO.2005.00.703","article-title":"Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma","volume":"23","author":"Mulhern","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104149_bib0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3747\/co.v16i6.435","article-title":"Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma","volume":"16","author":"Lafay\u2013Cousin","year":"2009","journal-title":"Curr Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104149_bib0009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1215\/15228517-2008-084","article-title":"Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy","volume":"11","author":"Rutkowski","year":"2009","journal-title":"Neuro-Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104149_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clon.2019.01.001","article-title":"Radiotherapy advances in paediatric medulloblastoma treatment","volume":"31","author":"Padovani","year":"2019","journal-title":"Clin Oncol R Coll Radiol G B"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104149_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10555-019-09840-2","article-title":"Drug repurposing towards targeting cancer stem cells in pediatric brain tumors","volume":"39","author":"Bahmad","year":"2020","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104149_bib0012","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrclinonc.2015.169","article-title":"Drug repurposing in oncology\u2013patient and health systems opportunities","volume":"12","author":"Bertolini","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ebiom.2022.104149_bib0013","article-title":"Repurposing drugs in oncology: from candidate selection to clinical adoption","author":"Pantziarka","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ebiom.2022.104149_bib0014","article-title":"Beta-blockers for congestive heart failure in children","volume":"7","author":"Alabed","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"10.1016\/j.ebiom.2022.104149_bib0015","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104149_bib0016","doi-asserted-by":"crossref","first-page":"797","DOI":"10.18632\/oncotarget.343","article-title":"Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment","volume":"2","author":"Pasquier","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2022.104149_bib0017","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ebiom.2016.02.026","article-title":"Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: a bench to bedside study","volume":"6","author":"Pasquier","year":"2016","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104149_bib0018","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/bjc.2013.205","article-title":"\u03b2-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma","volume":"108","author":"Pasquier","year":"2013","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104149_bib0019","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1667\/RR15193.1","article-title":"Adrenergic receptor signaling regulates the response of tumors to ionizing radiation","volume":"191","author":"MacDonald","year":"2019","journal-title":"Radiat Res"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104149_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050575","article-title":"Effects of \u03b2-adrenergic antagonists on chemoradiation therapy for locally advanced non-small cell lung cancer","volume":"8","author":"Chaudhary","year":"2019","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104149_bib0021","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41467-020-15676-0","article-title":"Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2022.104149_bib0022","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1748-717X-5-98","article-title":"Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro","volume":"5","author":"Liao","year":"2010","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.ebiom.2022.104149_bib0023","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2147\/DDDT.S160865","article-title":"The role of propranolol as a radiosensitizer in gastric cancer treatment","volume":"12","author":"Liao","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104149_bib0024","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.radonc.2014.05.014","article-title":"Earlier and sustained response with incidental use of cardiovascular drugs among patients with low- to medium-grade meningiomas treated with radiosurgery (SRS) or stereotactic radiotherapy (SRT)","volume":"111","author":"Pintea","year":"2014","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104149_bib0025","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mds616","article-title":"Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy","volume":"24","author":"Wang","year":"2013","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104149_bib0026","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1158\/0008-5472.CAN-06-3418","article-title":"Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors","volume":"67","author":"Zindy","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104149_bib0027","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccell.2018.02.006","article-title":"NRL and CRX define photoreceptor identity and reveal subgroup-specific dependencies in medulloblastoma","volume":"33","author":"Garancher","year":"2018","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104149_bib0028","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/1878-0261.12810","article-title":"In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor","volume":"14","author":"Ariey-Bonnet","year":"2020","journal-title":"Mol Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104149_bib0029","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1349-7006.2010.01582.x","article-title":"Role of beta1-adrenoceptor in increased lipolysis in cancer cachexia","volume":"101","author":"xing","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ebiom.2022.104149_bib0030","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1038\/s41598-017-05313-0","article-title":"Inhibition of \u03b2-glucocerebrosidase activity preserves motor unit integrity in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Henriques","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104149_bib0031","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet.journal"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104149_bib0032","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104149_bib0033","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104149_bib0034","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104149_bib0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104149_bib0036","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.18632\/oncotarget.13760","article-title":"Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models","volume":"8","author":"Rico","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2022.104149_bib0037","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2018","journal-title":"Redox Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104149_bib0038","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1874467211666180219102520","article-title":"COX-2 in radiotherapy: a potential target for radioprotection and radiosensitization","volume":"11","author":"Cheki","year":"2018","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104149_bib0039","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11864-020-00805-0","article-title":"Drug repurposing in medulloblastoma: challenges and recommendations","volume":"22","author":"Hammoud","year":"2020","journal-title":"Curr Treat Options Oncol"},{"issue":"suppl 1","key":"10.1016\/j.ebiom.2022.104149_bib0040","doi-asserted-by":"crossref","first-page":"I41","DOI":"10.1007\/s003950070008","article-title":"Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?","volume":"95","author":"Hjalmarson","year":"2000","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104149_bib0041","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mds616","article-title":"Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy","volume":"24","author":"Wang","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104149_bib0042","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mds616","article-title":"Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy","volume":"24","author":"Wang","year":"2013","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104149_bib0043","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/TA.0000000000002484","article-title":"Propranolol attenuates cognitive, learning, and memory deficits in a murine model of traumatic brain injury","volume":"87","author":"Zeeshan","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.ebiom.2022.104149_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104587","article-title":"\u03b2-blockers: their new life from hypertension to cancer and migraine","volume":"151","author":"Fumagalli","year":"2020","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104149_bib0045","doi-asserted-by":"crossref","first-page":"FSO190","DOI":"10.4155\/fsoa-2017-0003","article-title":"Ex vivo tumor culture systems for functional drug testing and therapy response prediction","volume":"3","author":"Meijer","year":"2017","journal-title":"Future Sci OA"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104149_bib0046","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/0883073815597758","article-title":"Advances in Radiation Therapy in Pediatric Neuro-oncology","volume":"31","author":"Bindra","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ebiom.2022.104149_bib0047","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3332\/ecancer.2015.499","article-title":"Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma","volume":"9","author":"Banavali","year":"2015","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104149_bib0048","doi-asserted-by":"crossref","first-page":"e60021","DOI":"10.1371\/journal.pone.0060021","article-title":"Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma","volume":"8","author":"Stiles","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104149_bib0049","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/COC.0000000000000768","article-title":"Concurrent \u03b2-blocker use is associated with improved outcome in esophageal cancer patients who undergo chemoradiation: a retrospective matched pair analysis","volume":"43","author":"Farrugia","year":"2020","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104149_bib0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajh.24582","article-title":"Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation","volume":"92","author":"Hwa","year":"2017","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104149_bib0051","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/cbt.10.1.11944","article-title":"\u03b22-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF\u03baB and AP-1","volume":"10","author":"Zhang","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"3\u20134","key":"10.1016\/j.ebiom.2022.104149_bib0052","doi-asserted-by":"crossref","first-page":"109","DOI":"10.18632\/oncoscience.413","article-title":"Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma","volume":"5","author":"Amaya","year":"2018","journal-title":"Oncoscience"},{"key":"10.1016\/j.ebiom.2022.104149_bib0053","doi-asserted-by":"crossref","first-page":"e43026","DOI":"10.7554\/eLife.43026","article-title":"R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma","volume":"8","author":"Overman","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.ebiom.2022.104149_bib0054","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41698-019-0099-9","article-title":"Propranolol exhibits activity against hemangiomas independent of beta blockade","volume":"3","author":"Sasaki","year":"2019","journal-title":"NPJ Precis Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104149_bib0055","doi-asserted-by":"crossref","first-page":"e151109","DOI":"10.1172\/JCI151109","article-title":"Non-\u03b2-blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma","volume":"132","author":"Seebauer","year":"2021","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.ebiom.2022.104149_bib0056","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.18632\/oncotarget.3595","article-title":"Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment","volume":"6","author":"Broh\u00e9e","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2022.104149_bib0057","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1038\/s41598-018-25340-9","article-title":"Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression","volume":"8","author":"Broh\u00e9e","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104149_bib0058","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/cancers10120476","article-title":"Propranolol promotes glucose dependence and synergizes with dichloroacetate for anti-cancer activity in HNSCC","volume":"10","author":"Lucido","year":"2018","journal-title":"Cancers"},{"issue":"7239","key":"10.1016\/j.ebiom.2022.104149_bib0059","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"Diehn","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104149_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7150\/thno.28033","article-title":"Enhancement of mitochondrial ROS accumulation and radiotherapeutic efficacy using a Gd-doped titania nanosensitizer","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104149_bib0061","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.juro.2007.01.019","article-title":"Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells","volume":"177","author":"Anai","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104149_bib0062","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.oraloncology.2003.09.005","article-title":"Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma","volume":"40","author":"Terakado","year":"2004","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104149_bib0063","first-page":"5959","article-title":"Inhibition of cyclooxygenase-2 sensitizes lung cancer cells to radiation-induced apoptosis","volume":"14","author":"Han","year":"2017","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104149_bib0064","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.drudis.2016.02.019","article-title":"The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers","volume":"21","author":"Salehifar","year":"2016","journal-title":"Drug Discov Today"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104149_bib0065","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00381-010-1190-2","article-title":"Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells","volume":"26","author":"Chen","year":"2010","journal-title":"Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104149_bib0066","doi-asserted-by":"crossref","first-page":"11013","DOI":"10.3390\/ijms150611013","article-title":"Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells","volume":"15","author":"Yang","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104149_bib0067","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1215\/15228517-2008-035","article-title":"Tumor-growth\u2013promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets","volume":"10","author":"Baryawno","year":"2008","journal-title":"Neuro-Oncol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422003309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422003309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:17:05Z","timestamp":1762456625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422003309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":67,"alternative-id":["S2352396422003309"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104149","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104149"}}